1. 2-ethyl-6-methyl-3-hydroxypyridine Succinate
2. 3-pyridinol, 2-ethyl-6-methyl-, Butanedioate (1:1) (salt)
3. Butanedioic Acid, Compd. With 2-ethyl-6-methyl-3-pyridinol (1:1)
4. Emoxypine Succinate
5. Methylethylpiridinol Succinate
6. Mexiprim
1. 127464-43-1
2. 2-ethyl-6-methylpyridin-3-ol Succinate
3. Emoxypine Succinate
4. 2-ethyl-3-hydroxy-6-methylpyridine Succinate
5. Emoxypine (succinate)
6. Butanedioic Acid, Compd. With 2-ethyl-6-methyl-3-pyridinol (1:1)
7. 2r985002ct
8. 2-ethyl-6-methyl-3-pyridinol Succinate (salt)
9. Mexiprim
10. Emicidine
11. 2-ethyl-6-methyl-3-hydroxypyridine Succinate
12. Methylethylpiridinol Succinate
13. 2-ethyl-6-methyl-3-pyridinol Succinate
14. Unii-2r985002ct
15. Emicidin
16. Mexicor
17. Cambridge Id 5110148
18. Schembl1010987
19. Dtxsid30155577
20. 3-pyridinol, 2-ethyl-6-methyl-, Butanedioate (1:1) (salt)
21. Bcp13396
22. Hy-w002620a
23. Mfcd00445612
24. Akos003239209
25. 2-ethyl-6-methylpyridin-3-olsuccinate
26. Ds-13730
27. Cs-0182823
28. E1069
29. Ft-0660570
30. Butanedioic Acid;2-ethyl-6-methylpyridin-3-ol
31. Methylethylpiridinol Succinate [who-dd]
32. T71674
33. 647m960
34. A805706
35. Q-100116
36. Q27255507
Molecular Weight | 255.27 g/mol |
---|---|
Molecular Formula | C12H17NO5 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 4 |
Exact Mass | 255.11067264 g/mol |
Monoisotopic Mass | 255.11067264 g/mol |
Topological Polar Surface Area | 108 Ų |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 198 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Psychotropic Drugs
A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). (See all compounds classified as Psychotropic Drugs.)
Platelet Aggregation Inhibitors
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)
Antioxidants
Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)
LOOKING FOR A SUPPLIER?